Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inactivated Hepatitis A Vaccine (Human diploid cell)
- Development stage
- Unknown
- Lead developer
- Sinovac Biotech
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The Inactivated Hepatitis A Vaccine (Human diploid cell) is an approved vaccine developed by AIM Honesty Biopharmaceutical, a subsidiary of AIM Vaccine Corporation. It is produced using the LV8 strain of the hepatitis A virus (HAV), which is cultured in the KMB17 human diploid cell line and subsequently inactivated. The vaccine is formulated with an aluminum adjuvant to enhance the immune response and is indicated for the prevention of hepatitis A infection in susceptible individuals aged 1 year and older. It is available in pediatric (320 EU) and adult (640 EU) formulations. The vaccine works by introducing inactivated HAV antigens to the body, stimulating the production of protective antibodies that provide immunity against future hepatitis A virus exposure.
- Brand names
- Healive
- Other names
- Hepatitis A Vaccine (Inactivated, Human Diploid Cell)Inactivated Hepatitis A VaccineAIM Honesty Hepatitis A Vaccine
Beyond the preview
Go deeper on Inactivated Hepatitis A Vaccine (Human diploid cell).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inactivated Hepatitis A Vaccine (Human diploid cell).